BANK OF AMERICA CORP /DE/ - GENETIC TECHNOLOGIES LTD ownership

GENETIC TECHNOLOGIES LTD's ticker is GENE and the CUSIP is 37185R208. A total of 12 filers reported holding GENETIC TECHNOLOGIES LTD in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of GENETIC TECHNOLOGIES LTD
ValueSharesWeighting
Q2 2019$0
-100.0%
5
-100.0%
0.00%
Q3 2017$52,000
-3.7%
60,721
+0.7%
0.00%
Q2 2017$54,00060,286
+150615.0%
0.00%
Q4 2016$040
+3900.0%
0.00%
Q3 2015$0
-100.0%
1
-99.7%
0.00%
Q1 2015$2,0003500.00%
Other shareholders
GENETIC TECHNOLOGIES LTD shareholders Q4 2017
NameSharesValueWeighting ↓
Alpine Global Management, LLC 28,437$30,0000.01%
Virtu Financial LLC 37,505$39,0000.00%
Renaissance Technologies 982,980$1,022,0000.00%
LADENBURG THALMANN FINANCIAL SERVICES INC. 2,750$3,0000.00%
JANE STREET GROUP, LLC 13,527$14,0000.00%
UBS Group AG 3,398$3,0000.00%
CITIGROUP INC 300$00.00%
MORGAN STANLEY 1,520$2,0000.00%
Financial Architects, Inc 350$00.00%
Cambridge Investment Research Advisors, Inc. 12,000$12,0000.00%
View complete list of GENETIC TECHNOLOGIES LTD shareholders